Key facts
- This page summarizes Betty D. Larson's Form 4 filing for Merck & Co., Inc. (MRK).
- 3 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 02 May 2024, 16:25.
Betty D. Larson - 30 Apr 2024 Form 4 Insider Report for Merck & Co., Inc. (MRK)
- Reporting relationship
- EVP, Chief HR Officer
- Issuer ticker
- MRK
- Reported as of
- 30 Apr 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 02 May 2024, 16:25:48 UTC
- Prior SEC filing
- 08 Apr 2024
- Next SEC filing
- 02 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kelly E. W. Grez as Attorney-in-Fact for Betty Larson
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Betty D. Larson filed Form 4 for Merck & Co., Inc. (MRK) on 02 May 2024.
Change
- Previous filing in this sequence was filed on 08 Apr 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MRK
transaction
Derivative
Restricted Stock Unit
Award
- Transaction value
- $0
- Shares
- +34,050
- Change %
- Price
- $0.000000
- Shares after
- 34,050
- Date
- 30 Apr 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 34,050
- Exercise price
- Footnotes
- F1, F2
MRK
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +58,594
- Change %
- Price
- $0.000000
- Shares after
- 58,594
- Date
- 30 Apr 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 58,594
- Exercise price
- $129.22
- Footnotes
- F3
MRK
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +31,055
- Change %
- Price
- $0.000000
- Shares after
- 31,055
- Date
- 30 Apr 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 31,055
- Exercise price
- $129.22
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
Footnote F2
These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027.
Footnote F3
The option vests and becomes exercisable in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027.
SEC remarks
See Exhibit 24 - Power of Attorney.